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Emergence of cationic polyamine dendrimersomes:
design, stimuli sensitivity and potential biomedical
applications
Partha Laskar *a and Christine Dufès *b
For decades, self-assembled lipid vesicles have been widely used in clinics as nanoscale delivery systems for
various biomedical applications, including treatment of various diseases. Due to their core–shell
architecture and versatile nature, they have been successfully used as carriers for the delivery of a wide
range of therapeutic cargos, including drugs and nucleic acids, in cancer treatment. Recently, surface-
modified polyamine dendrimer-based vesicles, or dendrimersomes, have emerged as promising
alternatives to lipid vesicles for various biomedical applications, due to their ease of synthesis, non-
immunogenicity, stability in circulation and lower size polydispersity. This mini-review provides an
overview of the recent advances resulting from the use of biomimetic hydrophobically-modified
polyamine-based dendrimersomes towards biomedical applications, focusing mainly on the two most
widely used polyamine dendrimers, namely polyamidoamine (PAMAM) and poly(propylene imine) (PPI)
dendrimers.
1. Introduction
Dendrimers are emerging as potential non-viral vectors for
efficiently delivering drugs and nucleic acids to the brain and
cancer cells. They are polymeric, nanometer-sized synthetic
molecules with perfectly branched multiple monomers that
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emerge radially from a central core similar to a tree (dendron in
Greek).1–4 Dendrimers consist of three main architectural
components: a reactant core molecule, which is considered the
origin of the dendrimer, highly branched polymeric layers (or
generations) that bind to the core in a specic way to form
a uniformly branched spherical macromolecule, and a multiva-
lent periphery.5,6 Their modiable surface functionalities, low
polydispersity and available internal cavities make them
particularly attractive as delivery systems for drug and gene
delivery applications.1,2,4–8 Recently, the ability of surface-
modied amphiphilic polyamine dendrimers to form self-
assembled nanostructures in water was the object of much
scrutiny. These amphiphilic dendrimers were synthesized by
conjugating various hydrophobic groups (i.e. aromatic, long
hydrophobic, uorinated chains) to the hydrophilic den-
drimers.5,9–13 The polyamine dendrimer-based vesicles, or den-
drimersomes, resulting from their self-assembly, have emerged
as promising delivery systems for various biomedical
applications.
The self-assembly of amphiphilic molecules in water is
a natural phenomenon resulting in various ordered thermody-
namically stable nano or microstructures, which is mostly
driven by various forces, such as hydrophobic interactions,
hydrogen bonding and metal–ligand interactions.14–17 Hydro-
phobic interactions are important factors causing the self-
assembly of amphiphilic molecules in aqueous solution,
which actually led to the rational design and synthesis of
various low- and high-molecular weight amphiphiles with
various hydrophobes towards nano or micro assemblies in the
last decades.18–21 Despite many potential applications, most
articial nanostructures constituted of low- and high-molecular
weight amphiphiles showed inherent drawbacks due to their in
vivo instability and inefficient delivery of cargos, which led this
eld evolving to develop enhanced nano-carriers for biomedical
applications, especially for the delivery of therapeutic agents in
cancer therapy.
Among various self-assembled nanostructures, vesicles,
three-dimensional entities with an aqueous lumen separated
from the outside aqueous medium by one or more hydrophobic
bilayer, are widely studied delivery systems as they resemble the
structure of naturally occurring cells, viral capsids or the
recently developed exosomes.22–26 They are advantageous over
other delivery systems for biomedical applications as they can
carry hydrophobic as well as hydrophilic cargos to the target site
of action. Several synthetic vesicles such as liposomes (lipid-
based vesicles), polymersomes (polymer-based vesicles) and
dendrimersomes (dendrimer-based vesicles) can mimic natural
carriers and are currently under investigation for various
biomedical investigations, such as therapy, diagnostic, analyt-
ical science and synthetic biology.
Over the years, the evaluation of natural and synthetic vesi-
cles for biomedical use appeared to follow the following time-
line: viral capsids (natural carriers, but immunogenic),
chronologically followed by liposomes (no immunogenicity, but
low stability), stealth liposomes (improved stability, but addi-
tional complexities due to the presence of several additives such
as cholesterol and poly(ethylene glycol) (PEG)), polymersomes
(high stability and longer circulation time, but high poly-
dispersity and poor control over size), and nally den-
drimersomes (high stability with low polydispersity, excellent
physical properties in the bulk state, high degree of branching
and a multiple number of end groups at the periphery) (Fig. 1
and 2).27–31
Fig. 1 Representation of various vesicular structures: (A) viral capsid, (B) liposome (or lipid-based vesicle), (C) stealth liposome (with additives
such as cholesterol and PEG), (D) polymersome (or polymer-based vesicle), (E) dendrimersome (or dendrimer-based vesicle). For clarity, only
single-bilayer vesicles were represented in this figure.
Fig. 2 Research articles cited in PubMed (search date: 10th March
2021) published from 2000 to 2021, corresponding to the keywords
“liposomes”, “viral capsids”, “polymersomes”, “dendrimersomes” (for
the category “particular vesicles”) and “liposomes in drug and gene
delivery”, “viral capsids in drug and gene delivery”, “polymersomes in
drug and gene delivery”, “dendrimersomes in drug and gene delivery”
(for the category “application in drug and gene delivery”).



























































































The formation of dendrimersomes has mainly been reported
from Janus type of dendrimers for various applications over the
years,30,32–34 which is synthetically challenging and involves more
time, organic solvents and synthetic skills. On the other hand,
a new generation of dendrimersomes made from cationic poly-
amine dendrimers is less synthetically challenging, less time
consuming, requires less organic solvents and less synthetic
skills. As a result, the evaluation of these vesicles was the focus of
much research, including the recent development of such den-
drimersomes towards anti-cancer therapy in our laboratory.
Much work has been devoted so far to the studies of poly-
amidoamine (PAMAM)-based amphiphilic dendrimers bearing
Fig. 3 Chemical structure of generation 1-diaminobutyric polypropylenimine (PPI) (A) and generation 1-polyamidoamine (PAMAM) dendrimers (B).
Fig. 4 Surface-modified amphiphilic dendrimers forming stimuli-responsive and non-stimuli-responsive dendrimer-based vesicles, or den-
drimersomes, presented in this review (color code for surface-modifying groups: lipids or aliphatic chains (blue), aromatic groups (green);
“double colored bar”: conjugated amphiphiles or hydrophobe–dendrimer conjugate, “/)”: complexed amphiphiles or hydrophobe–den-
drimer complex).



























































































long, so chains at their periphery.5,9–13,35 By contrast, it is only
recently that the aggregation behavior of another polyamine
hydrophilic dendrimer, poly(propylene imine) (PPI), was
investigated.36,37
This mini-review provides an overview of the development of
the self-assembled amphiphilic polyamine dendrimer-based
vesicles (dendrimersomes) towards potential biomedical
applications, including cancer therapy. As there is already a vast
amount of literature available on the formation of self-
assembled nanostructures derived from dendritic amphi-
philes made from Janus type of dendrimers,30,32–34,38–41 our
discussion will be restricted to the formation of vesicular self-
aggregated structures from surface-modied dendritic poly-
amine amphiphilic molecules, which corresponds to a more
recent development, focusing on PAMAM and PPI dendrimers,
that are the most promising polyamine cationic dendrimers




Recent developments of spontaneously formed den-
drimersomes from amphiphilic PPI dendrimer aer hydro-
phobic surface modication were reported in this part, which
was subdivided based on the type of hydrophobic modication
on the surface of PPI polyamine dendrimers, using various
lipids and aromatic groups. Additional stimuli-responsive
behavior, redox-sensitivity in particular, and gene transfection
capabilities of these dendrimersomes towards their successful
biomedical implication were further discussed in each of these
particular sections. Generation 3 (G3)-PPI dendrimer was
previously reported to be safer and more efficacious than its
higher generation counterparts for gene transfection in in vitro
and in vivo conditions.42–45 A polyethylene glycol (PEG)-based
heterobifunctional cross-linker (orthopyridyl disulde poly-
ethylene glycol succinimidyl carboxymethyl ester OPSS-PEG-
SCM) was used to conjugate the hydrophobic groups to G3-
PPI dendrimer, as PEG is a biocompatible material well
known to increase the water solubility of delivery systems and
a stealth material to reduce non-specic interactions with
circulatory proteins, thereby leading to an enhanced circulatory
lifetime of drug and gene delivery systems.26,46–49 Our recent
work also demonstrated that the conjugation of low molecular
weight PEG (2 kDa) to generation 3- and generation 4-PPI den-
drimers signicantly decreased their cytotoxicity as compared
to unmodied dendrimers, leading to increased gene expres-
sion on B16F10-Luc, A431, DU145 and PC3-Luc cells lines.50
2.1. Lipid-modied PPI dendrimers
2.1.1. Octadecyl chain-modied PPI dendrimer. We re-
ported the spontaneous formation of dendrimersomes by
octadecyl (C18) lipid chain-modied PEGylated G3-PPI den-
drimer for drug and gene delivery. Being essential structural
and functional hydrophobic constituents of animal cell
membrane,51–53 long fatty acid chains have always been
a preferred lipid choice for the conjugation to hydrophilic
substances towards the formation of self-assembled nano-
structures, as hydrophobic interactions are one of the main
driving forces for any amphiphilic low molecular weight
surfactants and high molecular weight polymers to self-aggre-
gate.54–56 Additionally, the presence of lipid chains conjugated
to the dendrimer backbone proved to enhance the overall
transfection capability of cationic polymers, including poly-
amine dendrimers, due to the strong fusogenic activity of lipids
and the formation of more compact, smaller-sized
Fig. 5 Chemical structure of an amphiphilic, surface-modified, disulphide-linked octadecyl chain-bearing/cholesterol-bearing/camptothecin-
bearing PEGylated generation 3-diaminobutyric polypropylenimine (PPI or DAB) dendrimer (DAB-PEG-S-S-ODT/DAB-PEG-S-S-CHOL/DAB-
PEG-S-S-CPT respectively), where m ¼ 45.



























































































dendriplexes.57–60 Furthermore, transfection activity was re-
ported to be enhanced for the octadecyl lipid-modied gener-
ation 3-PAMAM dendrimer.61 In line with that, we successfully
synthesized disulphide-linked octadecyl (C18 alkyl) or stearyl
chain-bearing PEGylated (MW 2 kDa) generation 3-PPI den-
drimer, or DAB-PEG-SS-ODT (Fig. 5) through one-pot in situ two-
step reactions, where the lipid : dendrimer ratio was nearly
1 : 1.62
We were unable however to synthesize octadecyl-bearing
PEGylated generation 3-PPI dendrimer at other ratios of lip-
id : dendrimer such as 2 : 1 or 1 : 2 due to freeze thawing issues,
which is a common problem for various cationic lipids and
emulsion-based foods.63,64 Stable, cationic, nanosized vesicles
were formed spontaneously from this dendrimer as a result of
molecular self-assembly above its critical aggregation concen-
tration value (50 mg mL1) (Fig. 6A and B). The hydrodynamic
diameter (dH) of these lipid–dendrimer-based dendrimersomes
showed a gradual decrease in average size from low to high
concentrations, due to the formation of more compact and
stable nanostructures as a result of increased hydrophobic
interactions among lipid parts with increasing concentration.
Thus, the sizes of DAB-PEG-SS-ODT-based vesicles at various
concentrations (260.8 nm  36.5 nm at 100 mg mL1, 221.4 nm
 39.4 nm at 200 mg mL1 and 162.1 nm  8.1 nm at 400 mg
mL1) were below the cut-off size for extravasation to most
tumor cells (400 nm) (Fig. 6C).65 DAB-PEG-SS-ODT-based vesi-
cles were found to bear a positive zeta potential at all the tested
concentrations, which increased with increasing concentra-
tions, reaching a maximum value of 2.43 mV  0.54 mV at
a concentration of 400 mg mL1 (Fig. 6C). The positive charge on
the surface of the vesicles helped to enhance the non-specic
uptake of these nanostructured cationic vesicles by the cells,
because of favorable electrostatic interactions between the
negatively charged cell membrane and positively charged
Fig. 6 (A) Measurement of CAC from the plot of relative fluorescence intensity (I/I0) of a hydrophobic fluorescent dye, N-phenyl-1-naph-
thylamine in presence of various lipid–dendrimer concentration in PBS buffer (pH 7.4). (B) Stained TEM images of lipid–dendrimer based
dendrimersomes (400 mg mL1 in PBS, pH 7.4) (bar size: 100 nm). (C) Size (-) and zeta potential (B) of dendrimersomes at various lipid–
dendrimer concentrations in PBS buffer (pH 7.4) at 37 C. AFM peak force error and height sensor images of 5 5 mm surfaces of (D) 200 mgmL1
and (E) 500 mg mL1 dendrimersomes adsorbed on a mica (silicon) surface (reproduced from ref. 62, with permission from the journal as authors
of this article).



























































































nanoparticles.66 The C18 lipid-bearing dendrimersome showed
a crystallization exotherm at 0.2–0.3 C and an adsorption
tendency on mica surface (Fig. 6D and E). These features were
more pronounced with increasing concentration of lipid–den-
drimer, indicating a linear relationship of such properties with
the content of conjugated lipid (Fig. 6D and E). The steady-state
uorescence intensity of emission maximum of coumarin-153
(C153) increased with increasing concentrations of den-
drimersomes, suggesting an increasing hydrophobicity of the
vesicular bilayer membrane with increasing lipid–dendrimer
concentration resulting from a more favorable packing of
amphiphiles. Overall a small blue shi (4 nm) of the emission
maximum of C153 was observed in presence of the den-
drimersomes than that in absence of dendrimersomes, indi-
cating a comparatively polar microenvironment of this vesicular
bilayer. Furthermore, the calculated micropolarity (p*-value ¼
0.83) of the hydrophobic microenvironment of bilayer at 1000
mg mL1 lipid–dendrimer solution was found to be similar to
the polarity of the polar aprotic solvent propylene carbonate
(0.83).67 The comparatively polar microenvironment of the
bilayer membrane made it less favorable for encapsulation of
a substantial amount of hydrophobic drugs. Because of the
Fig. 7 Unstained TEM images of low-cholesterol (A) and high-cholesterol (B) dendrimersomes (400 mg mL1 in PBS (pH 7.4)). Unstained TEM
images of dendrimersomes–DNA complexes: low-cholesterol (C and D) and high-cholesterol (E and F) dendriplexes at dendrimer : DNA weight
ratios of 5 : 1 (C and E) and 10 : 1 (D and F) (reproduced from ref. 68 with permission from the journal as authors of this article).



























































































presence of a disulphide linkage (–S–S–) in the backbone, this
lipid–dendrimer successfully showed a redox-responsive disin-
tegration of dendrimersomes in presence of a glutathione
(GSH) concentration similar to that of the cytosolic reducing
environment (10 mM GSH) in comparison to that of extracel-
lular reducing environment (10 mM GSH) or non-reductive
environment. In addition, this lipid–dendrimer was found to
condense more than 70–75% of the DNA at dendrimer : DNA
weight ratios of 5 : 1 and higher. Even aer the dendriplex
formation, the lipid–dendrimer had the capability to retain its
vesicular forming properties. Dendriplexes showed less
adsorption tendency on mica surface, leading to less deforma-
tion in comparison to that observed with the naked dendrimer.
The cationic, stable, nanometer-sized dendrimersomes-based
dendriplexes helped to enhance the cellular uptake of DNA
both at dendrimer : DNA weight ratios of 10 : 1 and 20 : 1,
respectively by up to 15.3-fold and 16.3-fold compared with
naked DNA on PC3 prostate cancer cell line. Similarly, in DU145
prostate cancer cell line, the cellular uptake of DNA increased
following treatment of the cells with this lipid-dendriplex by up
to 28.6-fold and 27.6-fold compared with naked DNA. The
dendriplexes showed an increased gene transfection on PC3 cell
line at both dendrimer : DNA weight ratios of 10 : 1 and 20 : 1
compared with naked DNA, whereas in DU145 cells transfection
was only enhanced at dendrimer : DNA weight ratio of 20 : 1.
Octadecyl chain-bearing PEGylated PPI dendrimer-based (DAB-
PEG-SS-ODT) dendrimersomes therefore were shown to be
promising as redox-sensitive drug and gene delivery systems for
potential applications in combination cancer therapy.
2.1.2. Cholesterol-modied PPI dendrimer. Since hydro-
phobic interactions are one of the main driving forces for any
aggregated structure, we have chosen to conjugate PEGylated PPI
dendrimer with a more lipophilic cholesterol moiety (instead of
comparatively less hydrophobic lipidic alkyl chains) to facilitate
comparatively more robust and efficient self-assembly and to
form more compact, smaller-sized dendriplexes.68 Due to its
higher hydrophobicity than that of the hydrocarbon chains of
fatty acids, cholesterol has been extensively utilized for the
synthesis of amphiphilic low molecular weight surfactant and
high molecular weight polymer-based self-assembled nano-
structures.69–71 Literature data suggested that cholesterol not only
helps to enhance the stability of the hydrophobic rigid micro-
environment of nanostructures and facilitate any drug delivery
systems to cross the cellular membrane, but also increase the
transfection efficacy of gene vectors due to its strong fusogenic
activity.6 In this study, we have reported the development of
redox-sensitive dendrimersomes as drug and gene delivery
systems comprising of disulde-linked cholesterol-bearing
PEGylated (MW 2 kDa) generation 3-PPI (or DAB-PEG-S-S-
CHOL) dendrimers (Fig. 5) via an in situ two-step reaction. In
this work, we have synthesized two cholesterol–dendrimers
where the ratio of cholesterol (and PEG) and PPI were 2 : 1 for
high cholesterol–dendrimer (12.5% conjugated cholesterol per
dendrimer) and 1 : 1 for low cholesterol–dendrimer (9.5%
conjugated cholesterol per dendrimer). Both of themwere able to
spontaneously self-assemble into stable, cationic, nanosized
vesicles (Fig. 7A and B) above their critical aggregation
concentrations (CAC:21 mgmL1 for low cholesterol dendrimer
and 10 mg mL1 for high cholesterol dendrimer). A lower CAC
value for high cholesterol–dendrimer vesicles in comparison to
the low cholesterol–dendrimer vesicle indicated that the overall
more hydrophobic content actually facilitates the den-
drimersome formation at lower lipid–dendrimer concentration.
These cholesterol–dendrimers showed comparatively lower CAC
values (and therefore self-assembly formation at lower lipid–
dendrimer concentration) than that of the C18 alkyl chain
modied dendrimers (mentioned in the previous section), due to
the higher hydrophobicity of cholesterol than the alkyl chain.
Both low- and high-cholesterol dendrimer-based den-
drimersomes displayed an average size less than 230 nmwith low
polydispersity index (PDI) values at all the tested concentrations,
with a gradual decreasing trend from low to high concentrations.
They showed the smallest sizes of 91.3 nm  11.3 nm and
133.4 nm  48.8 nm for low- and high-cholesterol dendrimer-
based dendrimersomes at 400 mg mL1 (among tested concen-
trations) respectively. The formation of more compact and stable
dendrimersomes at higher dendrimer concentrations due to
increased hydrophobic interactions among cholesterol was the
reason behind such a decrease in size. Both the dendrimersomes
showed positive zeta potential between 4 mV and 7 mV with an
increasing trend with increasing concentrations. The maximum
zeta potential values of 5.7 mV  0.5 mV and 6.5 mV  0.3 mV
was observed at 400 mg mL1 (among tested concentrations) for
low- and high-cholesterol dendrimer-based dendrimersomes,
respectively. The size and zeta potential of low- and high-
cholesterol dendrimersomes were not statistically different at
all the tested concentrations with the change of the amount of
cholesterol within the dendrimers. TEM images of the dried
samples on carbon coated copper grid revealed the formation of
spherical unilamellar vesicles of sizes less than 50 nm. These
dendrimersomes showed a successful entrapment of hydrophilic
and hydrophobic dyes. Both of them showed no lower critical
solution temperature (LCST) or cloud point (CT) in the temper-
ature ranging from 20 to 90 C, facilitating their no phase sepa-
ration of vesicles at body temperature (37 C), and therefore no
premature release of any entrapped pharmaceutically active
agent at body temperature. In DSC study, both the den-
drimersomes showed an endothermic melting peak (Tm) due to
the phase change of the vesicle membrane from the “gel” state to
the “liquid crystalline” or “uid” state at nearly 0 C (0.6 C and
0.8 C for low- and high-cholesterol dendrimer-based vesicles,
respectively) during the rst heating phase and second heating
cycle. Such a low Tm values for these dendrimersomes might be
due to the presence of unsaturation in cholesterol and/or in the
disulde bond. AFM images showed that both dendrimer-based
vesicles adsorbed on a freshly cleaved mica surface aer air-
drying, leading to the diffusion of the vesicles. Due to the pres-
ence of disulde-linked hydrophobic cholesterol in the bilayer of
dendrimer-based vesicles, they showed redox-sensitive properties
in presence of intracellular reducing environment (10 mM GSH).
It was found that both the dendrimersomes showed a gradual
increase in size over time in presence of a higher concentration
(10 mM) of GSH in comparison to that in the presence of 10 mM
or without GSH, which can be attributed to the cleavage of the



























































































disulde bonds and disintegration of vesicles, forming larger,
unstable and less compact aggregates in intracellular redox
condition. Both dendrimersomes showed a higher amount of
cumulative release of entrapped hydrophobic Nile red over time
from the vesicles in in the presence of a glutathione concentra-
tion similar to that of a cytosolic reducing environment (up to
40% and 25% Nile red release from low- and high-cholesterol
dendrimersomes respectively in the presence of 10 mM GSH)
rather than in extracellular redox condition. Thus the disas-
sembly of the vesicles and concomitant release of the model drug
in the intracellular or cytosolic reducing environment (corre-
sponding to 10 mM GSH) proved the possibility of future use of
these dendrimer-based vesicles as redox-responsive drug delivery
systems for cancer treatment. The high-cholesterol den-
drimersomes showed higher melting enthalpy (in DSC study),
increased adsorption tendency on mica surface (in AFM study),
have higher entrapment ability for hydrophobic drugs and dis-
played an increased resistance to redox-responsive environments
in comparison with their low-cholesterol counterpart due to
a progressive “dilution” of the lipids (cholesterol) in the bilayer
membrane from high- to low-cholesterol dendrimer-based vesi-
cles. Both dendrimersomes were able to condense plasmid DNA
quite efficiently along with the retention of their vesicular
structures aer complexation with DNA (Fig. 7C–F). Low-
cholesterol vesicles were able to condense more than 85% of
the DNA at all the tested dendrimer : DNA weight ratios, whereas
high-cholesterol vesicles having fewer primary amine at the
periphery, showed condensation ability over 85% at den-
drimer : DNA weight ratios of 1 : 1 and higher. Due to the pres-
ence of highly hydrophobic cholesterol in the backbone, these
dendriplexes showed an overall smaller hydrodynamic diameter,
leading to the formation of more compact dendriplexes in
comparison to not only DAB-PEG-S-S-ODT-based den-
drimersomes (described in the previous sections), but also the
unmodied DAB dendriplex. Both dendrimers showed positive
surface charge ranging between 21.4 0.9 and 41.1  0.6 mV for
most dendrimer : DNA weight ratios from 1 : 1 and above.
Further, both dendriplexes retained the vesicular morphology
aer complexation with DNA, as evidenced from the TEM images
of dendriplexes at dendrimer : DNA weight ratios of 5 : 1 and
10 : 1. Thus, positively charged and smaller-sized compact
dendrimersome-based dendriplexes enhanced the cellular
uptake of DNA through internalization mechanisms by up to 8–
12-fold and 10–15-fold when compared with unmodied G3-PPI
dendriplex and naked DNA respectively. Overall, these den-
driplexes helped to increase the gene transfection in the PC-3
prostate cancer cell line at various dendrimer : DNA weight
ratios, by about 5-fold compared with the gene expression
observed following treatment of the cells with naked DNA. These
cholesterol-bearing PEGylated dendrimersomes were more
promising as redox-sensitive drugs and gene delivery systems
than the C18 alkyl-bearing PEGylated dendrimersomes.
2.2. Aromatic group-modied PPI dendrimers
2.2.1. Camptothecin (quinoline alkaloid)-modied PPI
dendrimer. In spite of their advantages regarding the
combination delivery of drugs and genes, cholesterol-based
dendrimersomes (mentioned in Section 2.1.2.) may face the
undesired release of the entrapped drugs before reaching their
target site of action. To overcome this potential issue associated
with the physical entrapment of drugs in the delivery systems,
we have designed and synthesized a pro-drug dendrimer by
conjugating the anti-cancer drug camptothecin (CPT) with
PEGylated generation 3-diaminobutyric polypropylenimine
dendrimer (or DAB-PEG-S-S-CPT) through a redox-sensitive
disulphide linkage (Fig. 5) in a similar fashion as DAB-PEG-S-
S-ODT and DAB-PEG-S-S-CHOL.72 The ratio of CPT (and PEG)
and PPI was found to be nearly equal to 1 : 1 for the synthesized
CPT–dendrimer, DAB-PEG-S-S-CPT. This PEGylated pro-drug
dendrimer was found to spontaneously self-assemble into
cationic vesicles at pH 7.4. It formed the dendrimersomes above
a comparatively higher critical aggregation concentration (200
mg mL1) than that of lipid–dendrimer-based dendrimersomes
due to the lower hydrophobicity of CPT than that of lipid. The
hydrodynamic size of dendrimersomes measured at various
tested concentrations (0.5, 1 and 2 mg mL1) showed a sharp
decrease with time and increasing concentrations. The hydro-
dynamic sizes became steady aer 12 h at 37 C and remained
stable at around 250–300 nm (for 0.5 mgmL1) and 150–200 nm
(for 1 and 2 mg mL1), leading to the formation of more stable
and compact nanostructures at higher concentrations due to
increased hydrophobic interactions among CPT molecules. The
size of dendrimersomes in presence or absence of complete
medium containing 10% FBS (size 100 nm) was below the cut-
off size for extravasation. The formation of stable cationic
dendrimersomes at various tested concentrations (0.5–2 mg
mL1) was evidenced from the positive zeta potential (3–5mV)
for up to 7 days. TEM images revealed the unilamellar,
spherical-shaped vesicles (dendrimersomes) with a size lower
than 100 nm (Fig. 8A–C). The micropolarity (p*-value ¼ 0.278)
value obtained using coumarin-153 (C153) probe study sug-
gested that the polarity of hydrophobic bilayer microenviron-
ment was similar to the polarity of hexauorobenzene (0.27),
conrming that the vesicular bilayer was composed of the
aromatic benzene rings of CPT. The appearance of the shoulder
band in the uorescence spectrum of C153 indicated a distri-
bution of probe molecules at multiple locations in vesicular
assemblies. Circular dichroism (CD) spectra of den-
drimersomes (2 mg mL1) in phosphate buffer (pH 7.4) sug-
gested a chiral packing of the CPT moieties in the vesicular
bilayer with negative chirality and le-handed helical arrange-
ment. The CPT release from dendrimersomes (1 mg mL1 in
phosphate buffer, pH 7.4) was found to be around 10 to 15% in
non-redox and extracellular redox condition in normal cells (in
presence of 10 mMGSH). It sharply increased with time to about
30–35% within 7 days in presence of 10 mM GSH (equivalent to
the intracellular concentration in normal cells) and 70% in
presence of 50 mM glutathione (equivalent to the intracellular
environment of tumor tissue) due to the disintegration of
dendrimersomes. Additionally, the pro-drug dendrimer could
instantly condense more than 85% of the DNA at den-
drimer : DNA weight ratios of 5 : 1 and higher, forming stable
vesicular aggregates over time. Such stable and cationic



























































































dendrimersome–DNA complexes at dendrimer : DNA weight
ratios of 5 : 1 and higher led to an enhanced cellular uptake of
DNA (by up to 1.6-fold) and increased gene transfection (by up
to 2.4-fold) in prostate cancer cells in comparison with the
unmodied G3-PPI dendrimer (Fig. 8D). These redox-
responsive camptothecin-bearing cationic dendrimersomes
are therefore promising carrier-based delivery systems towards
combination cancer therapy involving chemotherapy along with
Fig. 8 TEM images of dendrimersomes formed by CPT–dendrimer solutions (pH 7.4) at various concentrations: 0.2mgmL1 (A), 1.0mgmL1 (B)
and 2.0 mg mL1 (C) (scale bar: 100 nm). (D) Confocal microscopy images of the cellular uptake of CPT–dendrimer conjugate complexed with
Cy5-labelled DNA (2.5 mg per well) at various weight ratios (control : DAB dendrimer : DNA) (magnification: 40) (reproduced from ref. 72 with
permission from the journal as authors of this article).



























































































gene therapy. Further, such a strategy could also be used for
synergistic combination of drugs and nucleic acids of interest
against any particular cancer. Moreover, due to the capability of
these drug-conjugated dendrimersomes to entrap various
hydrophobic and hydrophilic guests in their hydrophilic
aqueous core or hydrophobic bilayer, such dendrimersomes
could be used for theranostic applications by delivering
imaging agents in addition to therapeutic drugs and nucleic
acids to the disease site.73–75
2.2.2. Azobenzene- and palmitoyl-modied PPI den-
drimers. Tsuda and colleagues reported in 2000 the formation
of giant micrometer-sized spherical vesicles with a multi-
lamellar “onion-like” structure in aqueous solution below pH 8
from generation 5-PPI dendrimer functionalized with aliphatic
chains.37 Their study described the synthesis and characteriza-
tion of three surface-modied generation 5-PPI dendrimers 1, 2,
and 3, decorated with side chains containing 64 palmitoyl, 32
palmitoyl and 32 azobenzene, and 64 azobenzene groups
respectively (Fig. 9).
Transmission electron microcopy and confocal uorescence
microscopy experiments demonstrated the formation of
dendrimer-based giant vesicles in aqueous dispersion. Addi-
tionally, they demonstrated that the azobenzene-functionalized
vesicles (2 and 3) were able to uoresce, with amaximum at lmax
600 nm, due to the dense and ordered arrangement of the
azobenzene chromophore in the hydrophobic bilayer of the
vesicular aggregates. Hydrogen bonds between protonated
cores of the dendrimers (at pH < 8) and the p–p stacking of the
azobenzene moieties inside the bilayer (as evidenced by the
emission of the vesicles) were the main factors involved in the
stabilization of such micrometer-sized vesicles. The vesicular
structure and size distribution were found to be dependent on
the end groups at the periphery of the dendrimer and the pH of
the solution. Giant vesicles 2 and 3 have their morphology
altered along with the refractive index of the solution, upon
exposure to laser irradiation with 1064 and/or 420 nm light, as
(i) infrared light induced a structural rearrangement, and (ii)
420 nm light induced a cis–trans isomerization of azobenzene
units, leading to structural changes accompanied by an increase
in the emission intensity. Further, vesicles in an aqueous
solution at pH 1 showed an increase in uorescence intensity
with a blue shi of the emission maximum to 540 nm (due to
higher degree protonation of the vesicles only aer illumina-
tion), whereas this blue shi was not observed for vesicle
solutions in Milli-Q® water at pH 5.5. The enhanced uores-
cence intensity due to the reorganization of the chromophores
within the giant vesicles was attributed to the fact that the
kinetically formed giant vesicular systems in which the packing
of the liquid-crystalline azobenzene units were not optimal,
changed to a thermodynamically more relaxed state aer light-
induced isomerization.
2.2.3. Polystyrene-modied PPI dendrimer. In 1995, Meijer
group reported the formation of novel amphiphilic macromol-
ecules resulting from the conjugation of well-dened poly-
styrene (PS) moiety to PPI dendrimers of 5 generations
(Fig. 10).76
PS-dendr-(NH2)32, PS-dendr-(NH2)16 and PS-dendr-(NH2)8
respectively formed spherical micelles, micellar rods and
vesicular structures in aqueous phase, as demonstrated by
dynamic light scattering, conductivity measurements and
transmission electron microscopic studies. The lower genera-
tions of this class of amphiphilic macromolecules showed
invertedmicellar behavior in toluene, which was predominantly
determined by the apolar PS chain. Conductivity measurements
were used to assess the amphiphilic properties of PS-dendr-
(NH2)x in toluene–water mixtures as a function of the toluene/
water ratio, which actually helped to identify the point of
phase inversion from water to toluene as the continuous phase.
All lower generation amphiphiles displayed a strong tendency
to stabilize toluene as the continuous phase. The highest
inversion point was observed for PS-dendr-(NH2)16, which was
well beyond 50% toluene in volume. Further, the inversion
point of PS-dendr-(NH2)32 could not be determined, due to the
dendrimer insolubility in toluene. Based on the differences in
phase inversion from water to toluene, the authors suggested
various types of aggregation pattern by these amphiphiles due
to their different amphiphilic behavior. The DLS measurements
was not very conrmatory, especially for higher generation of
dendrimer, due to the clustering between the aggregates.
Finally, TEM study using three different techniques (negative
Fig. 9 Chemical structure of the surface-modified dendritic amphiphiles made of generation 5-poly(propylenimine) dendrimers 1, 2, and 3, with
the dendrimers decorated with side chains containing 64 palmitoyl, 32 palmitoyl, 32 azobenzene and 64 azobenzene groups, respectively.



























































































staining with uranyl acetate, Pt shadowing, and freeze fracture)
showed a clear change in aggregation pattern from PS-dendr-
(NH2)8 to PS-dendr-(NH2)32, from vesicles [for PS-dendr-(NH2)8]
to micellar rods [for PS-dendr-(NH2)16, 12 nm in diameter], to
spherical micelles [for PS-dendr-(NH2)32, 10 to 20 nm in diam-
eter], which is in qualitative agreement with the theory of Isra-
elachvili and colleagues on the relation between the type of
aggregation and the amphiphile molecular shape.77 Thus, the
size of the amphiphilic dendrimer head group played an
important role to form such various aggregates, from spherical
to inverted micelles. The vesicular structures formed by PS-
dendr-(NH2)8 showed a resemblance to the structure proposed
by Kunitake and colleagues.78 Their diameters (10 to 20 nm)
were in the same order of magnitude as the estimated bilayers
of the PS-dendrimer block copolymers. These amphiphiles were
reported to be closer in shape and in size as compared with





In this part, we have reported recent developments of sponta-
neously and non-spontaneously (stimuli-sensitive) formed
dendrimersomes from amphiphilic PAMAM dendrimer
Fig. 10 Chemical structure of polystyrene conjugated to the highest generation poly(propylene imine) dendrimer PS-dendr-(NH2)32.



























































































following hydrophobic surface modication. This section was
similarly subdivided based on the type of hydrophobic modi-
cation on the surface of PAMAM polyamine dendrimers using
various lipids and aromatic groups.
3.1. Lipid-modied PAMAM dendrimers
3.1.1. Octadecyl alkyl chain-modied PAMAM dendrimer
3.1.1.1. pH-Responsive dendrimersomes. In 2015, Doura and
colleagues reported the synthesis and characterization of pH-
responsive lipid-bearing PAMAM dendron-based vesicular
assemblies, formed following conjugation of two octadecyl
hydrophobic chains to amine-terminated generation 1-(G1)
polyamidoamine dendron (Fig. 11).11
The presence of two primary amines and two tertiary amines
in the lipid–dendron moiety made this dendrimer particularly
promising due to its dynamic molecular shape at various pHs. It
was able to form vesicle assemblies at neutral and alkaline pHs,
but its structure changed to a micelle-like structure below pH
6.4. DSC analysis of this lipid–dendrimer showed a sharp
endothermic peak (around 43 C) at pH 10 and 7.4, but
a broader endothermic peak with a gradual shi to a lower
temperature at pH below 6.0, indicating the formation of
a bilayer structure with a gel-to-liquid crystalline transition
around 43 C under neutral and alkaline conditions but not in
acidic condition. The pH-responsive property of the lipid–
dendrimer-based vesicles was conrmed by DLS study. The
hydrodynamic size of the vesicles was around 75 nm at pH 7.4,
whereas their diameter decreased to around 20 nm below pH
6.5 aer a structural shi from vesicles to micelles. This was
conrmed further by TEM imaging, which also showed the
formation of vesicles with a diameter around 100 nm at pH 7.4,
and the formation of micelles with diameter less than 20 nm at
pH 6.5 and pH 4.0. Furthermore, the lipid–dendron amphiphile
also produced sharp pH-responsive vesicles with high colloidal
stability in presence of PEG-lipid, which eventually transformed
to micelle-like structure at around pH 6.5. The PEG-
incorporated lipid–dendron vesicles were able to encapsulate
FITC-labeled ovalbumin (a water-soluble protein found in egg
white, with a molecular weight of 45 kDa) in their internal
aqueous space, and also acid-triggered its almost complete
release at pH 6.0. An efficient ovalbumin delivery from PEG-
incorporated dendron–lipid vesicles was also observed into
the cytosol of DC2.4 mouse dendritic cells aer internalization
through endocytosis. These pH-responsive dendrimersomes
showed a promising efficacy for cytoplasmic delivery of bioac-
tive molecules, such as proteins, indicating their future poten-
tial towards pH-responsive cancer therapy.
3.1.1.2. Temperature-responsive dendrimersomes. Kono and
colleagues reported, in 2011, the formation of temperature-
sensitive vesicles by a series of alkyl amide-PAMAM dendrons
with varying chain terminal moiety that undergoes a tempera-
ture-dependent transition through a change in hydration of
the vesicle surface.35 They synthesized PAMAM-based lipid–
dendrimers by conjugating amine groups of generation 2- (G2)
and generation 3- (G3) PAMAM dendrons with two octadecyl
chains, where the dendrimer and the lipid chains were used as
head group and hydrophobic tails, respectively (Fig. 12). They
also made these lipid–dendrimers temperature-sensitive by
modifying the thermosensitive isobutyramide (IBAM) groups at
every chain terminal of the dendron moiety to produce two
IBAM-based thermos-sensitive dendrimers, IBAM-G2-DL and
IBAM-G3-DL. To correlate their assumption on the impact of the
terminal groups with the change of temperature, they also
prepared lipid–PAMAM dendrimer with acetamide (ACAM)
groups at every chain terminal of the dendron moiety, ACAM-
G2-DL and ACAM-G3-DL.
The authors successfully demonstrated the temperature
sensitization of lipid-bearing dendrimer-based vesicles.
Temperature-sensitive IBAM-terminated lipid–dendrimers
showed an increase in the cloud point with decreasing pHs of
the dispersions, due to the protonation of the tertiary amines of
the PAMAM dendrimer leading to the enhanced hydration of
the conjugated lipid moiety at lower pH values. Transmission
electron microscopy conrmed the vesicular morphology of
IBAM-G2-DL assemblies in aqueous solution, with a diameter of
50–100 nm at 15 C. However, these vesicular assemblies were
changed to brous structures about 8–10 nm in thickness aer
10 min incubation at 50 C (higher than the cloud point of
IBAM-G2-DL). By contrast, the IBAM-G3-DL molecules not only
formed spherical vesicles with diameters of 100–200 nm at
15 C, but also were able to retain their spherical vesicular
morphology aer 10 min incubation above the cloud point,
indicating a fusion of vesicles during the incubation. Such
a morphology transition phenomenon of these lipid–
dendrimer-based vesicular assemblies below and above the
cloud point was also supported by DLS, AFM and SAXS proles
at various temperatures. In DSC measurements, ACAM-G2-DL
and ACAM-G3-DL displayed no endotherm, whereas the
Fig. 11 Chemical structure of amine-terminated, generation 1-polyamidoamine dendron bearing two octadecyl hydrophobic chains.



























































































IBAM-G2-DL and IBAM-G2-DL dendrimers showed clear endo-
thermic peaks in the same temperature region. These DSC
results demonstrated the importance of the dehydration of the
IBAM groups on the vesicle surface for the generation of such
endothermic peaks. Additionally, a concomitant increase of
cloud point with increasing ACAM content proved the enhanced
hydration of the surface of the assemblies due to the inclusion
of hydrophilic ACAM groups. Thus, in contrast to IBAM-G2-DL,
ACAM-G2-DL dispersion was found to be stable under the
experimental conditions.
3.1.1.3. Adaptive dendrimersomes upon interaction with
siRNA. Liu and colleagues reported, in 2014, the formation of C-
18 alkyl chain-modied amphiphilic PAMAM dendrimer-based
dendrimersomes that were able to spontaneously re-assemble
into comparatively smaller-sized spherical micelles upon
interaction with siRNA.79 The amphiphilic, adaptive PAMAM
dendrimer (AD) was synthesized by conjugating two precursors
(azide-functionalized hydrophilic dendrimer moiety and
alkyne-functionalized two C-18 alkyl-bearing hydrophobic
moiety) through click chemistry (Fig. 13).
The amphiphilic AD could self-assemble in water into
spherical unilamellar vesicles of about 200 nm in diameter, as
demonstrated by DLS and TEM studies. Additionally, TEM
images showed a bilayer structure (corona of the vesicles) of
Fig. 12 Chemical structure of (A) generation 2- and (B) generation 3-PAMAM dendrimer conjugated to two octadecyl chains (R¼ isobutyramide
(IBAM) or acetamide (ACAM) terminal groups).



























































































7 nm thickness, which is approximately twice the theoretical
length of AD (3.5 nm). Furthermore, the formation of Lang-
muir monolayer lm at the air/water interface indicated a lipid-
like behavior and vesicle-forming properties of amphiphilic AD.
The authors observed an adaptive supramolecular assemblies
formed by AD upon interaction with siRNA, where AD-
dendrimersomes underwent structural rearrangement to form
nanosized siRNA/AD complexes. Such siRNA/AD complex-based
spherical substructures of 6–8 nm in diameter (twice the size of
AD) indicated the formation of micellar nanostructures. This
structural transition from the larger-sized vesicles into smaller-
sized micelles upon complexation with siRNA helped to expose
the positively charged dendrimer surface area, therefore
providing better stabilization of complexes through electro-
static interactions with the negatively charged siRNA. Addi-
tional mesoscale computational studies using dissipative
particle dynamics (DPD) supported that AD self-assembled into
large supramolecular structures, and planar section demon-
strated the formation of double-layered dendrimersomes. The
presence of siRNA actually destabilized the balance between the
two opposing forces, hydrophobic interactions among conju-
gated alkyl chains (favorable for cooperative construction of the
Fig. 13 Chemical structure of lipid-modified amphiphilic PAMAM dendrimer (AD) obtained by conjugating two precursors (azide-functionalized
hydrophilic dendrimer moiety and alkyne-functionalized C-18 alkyl bearing hydrophobic moiety) through click chemistry.
Fig. 14 Chemical structure of amphiphilic lipid-modified PAMAM dendrimers GnQPAMCm (where n¼ 1 (dendrimer generation) andm¼ 8, 12, 16
(alkyl chain length after the modification of the end group)).



























































































supramolecular assemblies), and repulsive interactions/steric
effects among the positively charged head groups of amphi-
philic dendrimers, leading to structural changes. These stable
siRNA–AD nano-assemblies effectively delivered siRNAs to
various cell lines in comparison to the commercially available
vector Lipofectamine RNAiMAX® (lipo), including PBMC-CD4+
human primary peripheral blood mononuclear cells, HSC-
CD34+ hematopoietic stem cells and glioblastoma stem cells
(GSCs) towards the development of successful non-viral vectors
for delivery of RNAi therapeutics. These siRNA–AD nano-
complexes were resulted in 50% reduction of viral infection in
both PBMC-CD4+ and HSC-CD34+ cells. Furthermore, the
signicant reduction of gene silencing ability of AD/siRNA
complex in the presence of balomycin A1 (a proton pump
inhibitor) proved that the proton sponge effect (protonation of
tertiary amines in the dendrimer interior leading to endosomal
disruption and subsequent cargo release in the cytoplasm) was
highly important for successful AD-mediated siRNA delivery.
3.1.2. Hexadecyl or C16 (fatty acid) chain-modied PAMAM
dendrimer
3.1.2.1. Balance of hydrophobic and hydrophilic groups. In
2015, Zhang and colleagues reported the self-aggregation of
a series of amphiphilic GnQPAMCm (where n ¼ 1 (dendrimer
generation) and m ¼ 8, 12, 16 (alkyl chain length aer the
modication of the end group)) lipid-modied PAMAM den-
drimers, formed by the conjugation of the same hydrophilic
group (generation-1 PAMAM) to alkyl groups of various chain
length in aqueous solution (Fig. 14).13
The authors observed signicant differences in the
morphology of self-aggregates of amphiphiles with their
chemical structures or with the change of hydrophobic and
hydrophilic balance of amphiphiles, more specically with the
chain length of alkyl groups attached to the dendrimer surface.
Cryo-TEM images conrmed the formation of spherical aggre-
gates with a particle size of 50–100 nm for all G1QPAMCm, which
was in agreement with DLS results. The aggregates of
G1QPAMC8 were irregularly spherical, unlike the regular
spherical shape observed for those made of G1QPAMC12 and
G1QPAMC16. Additionally, only G1QPAMC16 (with an alkyl chain
length of 16) was able to form 50–100 nm vesicles with clear
boundaries in comparison to the other two amphiphiles
G1QPAMC8 and G1QPAMC12. Critical micelle concentration was
found to decrease with the increase in chain length, though not
linearly indicating a differentiation in themorphology. With the
help of uorescence studies using two hydrophobic uorescent
probes pyrene and DPH, the authors revealed (i) a lower
polarity, (ii) higher solubilization ability of microdomains of
such self-aggregates and (iii) enhancement of the hydrophobic
microenvironment with the increase in alkyl chain length from
C8 to C12. In contrast, for G1QPAMC16 amphiphile, they
observed an increase not only in the polarity of the micro-
domain of aggregates (in comparison to that of G1QPAMC12)
but also a sharp hydrophobic probe solubilization ability,
indicating a boundary structure (bilayer or multilayer) within
the vesicular aggregates. The thermodynamic properties and
related parameters also helped to understand the formation of
aggregates with various morphologies. The enthalpies of
micelle formation (or DHmic values) for G1QPAMC8,
G1QPAMC12, and G1QPAMC12 were 2.3, 8.5, and
5.2 kJ mol1, respectively, indicating that the enthalpy and
entropy jointly contributed in the self-assembly process of the
amphiphilic G1QPAMCm. An enhancement of absolute value of
the enthalpy, from 2.3 kJ mol1 (G1QPAMC8) to 8.5 kJ mol1
(G1QPAMC12), proved the dominating impact of enhanced
hydrophobic interactions with the increase in alkyl chain
length, whereas for G1QPAMC16, the decrease in the absolute
value of the enthalpy indicated an opposite feature. It was found
that the ratios of theoretical alkyl chain length/radius are less
than one for G1QPAMC8 (10.16/19.77) and G1QPAMC12 (15.24/
19.77), and higher than one for G1QPAMC16 (20.32/19.77),
indicating that the head group of such amphiphiles also
played an important role along with the hydrophobic interac-
tions in the self-aggregation process and thereby enthalpy
changes. Such an alkyl chain length/radius value (higher than 1)
for G1QPAMC16 led to the conclusion that the intra-cohesion of
the alkyl chain (C16) was involved in the process of self-
assembly of the lipid-modied dendrimer, which resulted in
the weakening of the hydrophobic interactions and thereby in
the increase in DHmic.
3.2. Aromatic group-modied dendrimers
3.2.1. Aniline pentamer (AP) modied-dendrimer. Hung
and colleagues reported the formation of bilayer vesicular
assembly from a series of PAMAM dendrimer-based amphi-
philes, synthesized by conjugating various generations (G2–G5)
of hydrophilic PAMAM dendrimer with a hydrophobic shell of
aniline pentamer (AP) (Fig. 15).10
Fig. 15 Structure of aniline pentamer (AP) conjugated to various generations (G2–5) of PAMAM dendrimer, forming PAMAM-AP amphiphiles
(where R ¼ aniline pentamer, n ¼ average number of AP groups).



























































































The CAC of such AP-modied dendrimers self-assembled to
vesicular aggregates in water were not only very low (106–107
M), but also decreased with increasing generation of PAMAM.
This trend suggested that the formation of vesicles is favored in
the order G5 > G4 > G3 > G2, as the higher-generation (G4 and
G5) amphiphilic PAMAM-AP dendrimers holds stronger self-
organization tendency due to the p–p interactions among AP
units and the H-bonding interactions between the dendrimer
branches. The TEM images of PAMAM-AP G2–5 demonstrated
the formation of 100–200 nm spherical vesicular aggregates,
with gradually decreasing size of the bilayer vesicles as the
dendrimer generation increased from G2 to G5, due to the
loosely held nanostructures for the lower-generation den-
drimers. These vesicles were very adhesive due to the presence
of exible hydrophilic dendritic branches in the outer layer,
leading to a stronger self-adhesion via H-bonding interactions
of the branches for the higher-generation dendrimers than for
the lower-generation counterparts. Moreover, due to the strong
p–p interactions of the long hydrophobic rigid AP units in the
self-assembled nanoarchitectures, the average thickness of the
hydrophobic interphase was reduced to 1.7–2.1 nm, which is
well below the head-to-head theoretical distances (4.8 nm) of
the AP double layer. Stained TEM images with uranyl acetate
showed exactly reversed images in comparison to the unstained
images, as the outer and inner layers of the vesicles appear in
black with negative staining leading to the conclusion that the
hydrophilic dendritic branches are localized in this region. TEM
images also conrmed the presence of multiple aggregates
containing two vesicles (twins for G2-PAMAM-AP and G3-
PAMAM-AP) and multi-vesicles (large number of multiple
aggregates for G4-PAMAM-AP and G5- PAMAM-AP), due to the
increased number of hydrophobic AP units in the outer
periphery group of the PAMAM dendrimers. Moreover, SEM and
AFM images of G2- and G4-PAMAM-AP supported the self-
assembly formation of vesicles of various diameters. The
packing parameters of G2–G5-PAMAM-AP were found to be in
the range of 0.5–1.0 (as evaluated from EDX O-mapping
images), supporting the formation of bilayer vesicular struc-
tures. Comparatively larger-sized vesicles were observed under
acidic and alkaline conditions, in comparison to that in neutral
medium for each generation of amphiphilic dendrimers. At low
pH, the generation of ammonium salts from the tertiary amine
groups of PAMAM-AP helped to form the polarons from AP units
by doping with strong acids, which eventually increased the
stability of vesicular aggregates at low pH than that in double
distilled water. At high pH, the deprotonation of PAMAM-AP
amphiphiles enhanced p–p interactions, leading to the
formation of twins or multilayered vesicles. X-ray diffraction
(XRD) analyses of the vesicles helped to elucidate the possible
molecular packing patterns of G2–G5-PAMAM-AP along with
self-assembly driving force analysis. XRD patterns conrmed
the presence of a more ordered structure for these higher
generation amphiphilic dendrimers, due to the crystallization
induced by the result of enhanced p–p interactions (compacted
effect) of the strongly emeraldine APs.
3.2.2. Dansyl or 1-(naphthalenyl)-2-phenyldiazene (NPD)
shell-modied dendrimer. Wang and colleagues reported the
formation of vesicular assembly from a series of surface modi-
ed amphiphilic PAMAM dendrimers, which were synthesized
by conjugating various generations (G0–G5) of hydrophilic
PAMAM dendrimer with hydrophobic aromatic dansyl (DNS) or
1-(naphthalenyl)-2-phenyldiazene (NPD) groups.80 The surface
of G0- to G5-PAMAM dendrimers was modied with DNS and
NPD groups via sulfonylation and a Michael addition reaction
respectively to prepare a series of two different set of amphi-
philes, namely PAMAM–DNS and PAMAM–NPD (Fig. 16).
AFM and TEM imaging demonstrated the presence of
spherical vesicular aggregates of PAMAM–NPD amphiphiles in
water, with an average diameter about 100 nm and a bilayer
thickness of about 3.2–5.0 nm. DLS study clearly depicted an
increase in hydrodynamic radius with increasing generations
for PAMAM–NPD-based vesicles (78.4 nm for G0, 57.7 nm for
G1, 75.7 nm for G2, and 113.0 nm for G3), whereas no ordered
aggregates were obtained for dendrimers with generations
higher than G3. Furthermore, PAMAM–DNS also formed vesic-
ular structures with an average diameter of about 135 nm and
a bilayer thickness of about 3.2 nm in water. A p–p interaction
due to the presence of rigid and short aromatic groups at the
periphery of amphiphilic PAMAM dendrimers played an
important role, in addition to the amphiphilic nature of
modied dendrimers, in the self-assembly process towards
vesicle aggregates. This p–p interaction, along with
Fig. 16 Chemical structure of modified generation 0 to 5 PAMAM dendrimers conjugated to hydrophobic aromatic dansyl (DNS) or 1-(naph-
thalenyl)-2-phenyldiazene (NPD) groups, via sulfonylation and a Michael addition reaction respectively.



























































































hydrophobic interactions among hydrophobic aromatic moie-
ties conjugated on dendrimer surface, helped these aromatic
hydrophobic groups to align in parallel to form the hydrophobic
interphase between bilayers to get an energy minimum in water.
Upon UV irradiation of NPD groups, G0- to G2-PAMAM–NPD
amphiphiles showed the retention of vesicular structures with
an increase in aggregate size and a slight decrease in thickness
of the vesicle's bilayer due to the photo-isomerization, from the
more stable trans form to the less stable cis form, of NPD groups
leading to a change from a hydrophobic bilayer into a partially
interdigitated layer. Based on the measurement of uorescence
intensity of the PAMAM–DNS aggregates in water with
increasing dendrimer concentration, the critical aggregation
concentration (CAC) values were found to decrease from 6.79 
105 to 4.04  105 to 8.79  106 to 5.67  107 M as the
generation increased from G0 to G3. This gradual decrease
indicated that the aggregate formation was favorable with
increasing generation in the order of G3 > G2 > G1 > G0, due to
increased p–p interactions in aromatic rings and H-bonding
interaction among the dendrimer branches. The aggregation
values also decreased from 1.22  104 for PAMAM–NPD G0 to
8.79  102 for PAMAM– NPD G3, which is a strong indication of
decreasing CAC values with increasing generation of den-
drimers. Additionally, the calculated critical packing parameter
(Pc) values for these aggregates were within the range of 0.5–1.0,
supporting the formation of bilayer vesicular aggregates by
these amphiphiles in accordance with what observed on TEM
images. Cyclic voltammetry, a well-known electroanalytical
technique, was used to study the properties of electroactive DNS
units attached to PAMAM dendrimer. The cyclic voltammo-
grams of DNS-modied PAMAM dendrimers (G0 to G4) showed
a gradual increasing tendency of oxidation potentials with the
dendrimer generations (0.77 V for G0- to 0.88 V for G4-
dendrimer). This result suggested a gradual decrease in
electro-donating ability of PAMAM–DNS with increasing
generations, which might be attributed to the more crowded
groups at the periphery of the dendrimers at higher genera-
tions, as evidenced from a sharp decrease in diffusion coeffi-
cients with increasing generation.
3.2.3. Formation of vesicles based on ionic and p–p
interactions. Gröhn and colleagues reported the successful
formation of self-assembled supramolecular vesicles due to
electrostatic interactions between the cationic G8-
poly(amidoamine) dendrimer and the trivalent sulfonate dye
Ar27 in aqueous solution, by the so-called counterion conden-
sation (Fig. 17).81
Through their investigation based on the results obtained
from dynamic light scattering (DLS), static light scattering
(SLS), small-angle neutron scattering (SANS), confocal laser
scanning microscopy (CLSM) and uorescence correlation
spectroscopy (FCS), they have identied the importance and
interplay of electrostatics, p–p interactions and geometric
factors between G8-PAMAM dendrimer and Ar27 towards such
vesicle formation, even in the absence of any conventional
amphiphiles. In order to form vesicles by electrostatic self-
assembly, the pH of the solution was kept at such values
where amine groups of the dendrimer were positively charged
and all sulfonate groups of the dye were negatively charged. DLS
study showed the presence of stable aggregates in aqueous
solution when using dendrimer excess and a ratio of sulfonate
groups to primary amine groups of 1.1 : 1. The hydrodynamic
radius of such stable vesicles (RH ¼ 130 nm) remained the same
aer at least 48 h. In presence of a dendrimer excess, small
species probably corresponding to non-aggregated excess den-
drimer were found to coexist, whereas growth and precipitation
were observed in presence of a dye excess. SLS analysis of their
nanoscale structure showed a linear behavior in a Zimm plot
with a radius of gyration RG ¼ 128 nm, indicating the presence
of hollow spheres (as the shape sensitive parameter RG/RH ¼ 1),
different from solid spheres (RG/RH ¼ 0.775). RG/RH was found
to be constant (RG/RH ¼ 1.00  0.05) in spite of the variety of the
sizes (RH) of multiple samples between 110–140 nm. In SANS
study, the slope around 2 of the scattering curve (in a log/log
representation) at low q (aer the Guinier regime) conrmed
the presence of thin at structures. Thus such stable aggregates
with equal hydrodynamic radius and radius of gyration were
identied as the hollow spheres with a thin shell, or vesicles,
where all mass points were located on the shell. Moreover, the
Fig. 17 Chemical structure of the cationic generation-8 PAMAM dendrimer and the anionic trivalent sulfonate dye Ar27.



























































































vesicles formed by interactions between two non-uorescent
dendrimer building blocks and Ar27, successfully served as
hosts for a zwitterionic uorescent dye, FRM 480. This dye did
not cause any aggregation with either of the cationic and
anionic building blocks because of its zwitterionic nature. The
size of these vesicles (RH  140 nm) did not appear to be
impacted by such dye encapsulation, as evidenced from DLS
study, but the vesicles became visible through CLSM study due
to the encapsulation of this uorescent dye in their microen-
vironment. Following imaging of dye-loaded vesicles on mica
surface, the formation of un-sharp and ‘‘diffuse’’ particles was
observed due to the movement of the particles on mica surface
as a result of weak immobilization between negatively changed
mica surface and positively charged vesicles. Also, the uores-
cence correlation spectroscopy (FCS) of the vesicles showed
a radius of 1 and 150 nm for only dye and the dye–vesicle system
respectively supporting DLS results. Additionally, the vesicles
have been shown to be able to encapsulate uorescently labeled
10 kDa peptide, showing their future potential use in drug
delivery.
4. Conclusion and perspectives
Polyamine dendrimer-based vesicles, or dendrimersomes, have
demonstrated to be highly promising delivery systems of ther-
apeutic genes and drugs for various biomedical applications.
This mini-review focused on dendrimersomes prepared from
hydrophobically surface-modied hydrophilic PPI and PAMAM
dendrimers, as these two dendrimers are currently the most
widely used and promising polyamine dendrimers. Additional
cationic charges on the surface, stimuli-sensitivity (such as pH,
redox, light and temperature) of such dendrimersomes made
from various amphiphilic dendrimers helped them to be used
as nano-carriers for drugs and genes and to release their cargo
in cancer cell-specic environment. The lipid-modied PPI
dendrimers were found to form more stable dendrimersomes
(with lower CAC) than the drug-modied PPI dendrimers. In
addition, cholesterol-modied PPI dendrimersomes showed
more efficacy than the fatty acid chain-modied PPI den-
drimersomes as drug and gene delivery systems. These lipid-
modied, stimuli-responsive polyamine dendrimersomes
could be used for drug–gene combination cancer therapy, due
to their ability to encapsulate drugs, to form stable complexes
with nucleic acids and to enhance overall transfection. They
could also be used in future theranostic applications, as a result
of their potential entrapment of a therapeutic agent together
with an imaging agent.
Although the therapeutic, diagnostic, biosensor efficacies
and safety of the dendrimersomes are yet to be conrmed in
vivo, the early ndings of the described studies show that such
platforms hold a promising future in cancer management. A
further analysis of the structure–property correlation of these
newly developed polyamine dendrimersomes should facilitate
their development into even more efficacious delivery systems.
Overall, because of their ease of preparation, low immunoge-
nicity, embedded stimuli-sensitivities and multifunctional
architecture, these polyamine dendrimersomes are likely to be
used in therapeutic strategies combining targeting, imaging,
diagnostics and therapy. Continued research in this area should
therefore enable the preparation of highly specic, highly effi-
cacious dendrimersomes towards the treatment of cancer and
other biomedical applications.
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